UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000002851
Receipt number R000003481
Scientific Title A large-scale clinical study to investigate the secondary preventive effect of strict antihypertensive therapy in patients with a previous history of strok
Date of disclosure of the study information 2010/01/31
Last modified on 2021/05/23 16:12:49

No. Disposal Last modified on Item of update
1 Insert 2009/12/06 02:09:50
2 Update 2009/12/06 02:19:52 Date of disclosure of the study information
3 Update 2010/12/18 15:59:05 Recruitment status
Anticipated trial start date
4 Update 2012/07/06 09:51:17 Institute
Organization
Organization
Post marketing survey by drug manufacture etc., specified by Japanese law.
Organization1
Address1
Tel1
Email1
5 Update 2014/07/30 16:53:27 Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Last name of contact person
Last name of contact person
Organization
Division name
Division name
Address
Address
TEL
Homepage URL
Email
Organization
Division name
Division name
Address
Address
TEL
Email
Institute
Organization
Organization
Category of Funding Organization
Nationality of Funding Organization
Nationality of Funding Organization
Organization1
Secondary IDs
Study ID_1
Org. issuing International ID_1
Org. issuing International ID_1
Institutions
6 Update 2014/07/30 17:05:35 Condition
Condition
Classification by specialty
Narrative objectives1
Basic objectives2
Basic objectives -Others
Basic objectives -Others
7 Update 2014/07/30 17:08:30
Target sample size
8 Update 2014/07/30 17:09:59 Last follow-up date
9 Update 2016/12/15 12:21:58 Primary outcomes
Primary outcomes
Key secondary outcomes
Key secondary outcomes
10 Update 2016/12/15 12:28:33 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
URL releasing protocol
11 Update 2016/12/15 12:35:09 Narrative objectives1
Key secondary outcomes
12 Update 2016/12/15 14:36:07 Interventions/Control_1
Interventions/Control_1
Interventions/Control_2
Interventions/Control_2
Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
13 Update 2016/12/15 15:00:45 Organization
Address
Address
TEL
Organization
Organization
Name of primary person or sponsor
Institute
Organization
Organization
Organization1
Address1
14 Update 2018/06/12 11:38:17 Address
Address
TEL
Address
Address
Institutions
15 Update 2018/06/12 11:40:32 Date trial data considered complete
Date analysis concluded
16 Update 2021/05/23 15:24:46 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Institute
Organization
Organization
Address
Address
Tel
Email
17 Update 2021/05/23 16:12:49 Date of IRB
Anticipated trial start date